Amanda L Elchynski, Pharm.D., BCPS
Adjunct Professor
Department:
PTR Entrepreneurial Programs
Business Email:
aelchynski@ufl.edu
Teaching Profile
Courses Taught
2023-2024
PHA6120 Foundations of Precision Medicine: Pharmacogenomics
2023-2024
PHA6935 Selected Topics in Pharmacy
2024
PHA6137 Clinical Pharmacogenomics Implementations
Publications
2024
Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic.
Clinical and translational science.
17(7)
[DOI] 10.1111/cts.13890.
[PMID] 39046302.
2023
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype.
Clinical pharmacology and therapeutics.
113(5):973-985
[DOI] 10.1002/cpt.2735.
[PMID] 36049896.
2023
Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
80(15):994-1003
[DOI] 10.1093/ajhp/zxad099.
[PMID] 37166240.
2022
Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.
Implementation science communications.
3(1)
[DOI] 10.1186/s43058-022-00300-7.
[PMID] 35568931.
2022
Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team Setting.
Journal of personalized medicine.
12(4)
[DOI] 10.3390/jpm12040599.
[PMID] 35455715.
2022
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
Clinical and translational science.
15(2):371-383
[DOI] 10.1111/cts.13154.
[PMID] 34562070.
2021
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease.
The pharmacogenomics journal.
21(6):657-663
[DOI] 10.1038/s41397-021-00244-6.
[PMID] 34075203.
2021
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.
Clinical pharmacology and therapeutics.
110(3):677-687
[DOI] 10.1002/cpt.2354.
[PMID] 34231197.
2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Genetics in medicine : official journal of the American College of Medical Genetics.
23(12):2335-2341
[DOI] 10.1038/s41436-021-01269-9.
[PMID] 34282303.
2021
Utilizing a Human-Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support.
Journal of personalized medicine.
11(11)
[DOI] 10.3390/jpm11111227.
[PMID] 34834578.
2020
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.
Journal of clinical medicine.
9(7)
[DOI] 10.3390/jcm9072274.
[PMID] 32708920.
2020
Genotype-Guided Hydralazine Therapy.
American journal of nephrology.
51(10):764-776
[DOI] 10.1159/000510433.
[PMID] 32927458.
Contact Details
Emails:
- Business:
- aelchynski@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100486
GAINESVILLE FL 32610